Your browser doesn't support javascript.
loading
Phosphodiesterase 5 inhibitor treatment and survival in interstitial lung disease pulmonary hypertension: A Bayesian retrospective observational cohort study.
Dawes, Timothy J W; McCabe, Colm; Dimopoulos, Konstantinos; Stewart, Iain; Bax, Simon; Harries, Carl; Samaranayake, Chinthaka B; Kempny, Aleksander; Molyneaux, Philip L; Seitler, Samuel; Semple, Thomas; Li, Wei; George, Peter M; Kouranos, Vasileios; Chua, Felix; Renzoni, Elisabetta A; Kokosi, Maria; Jenkins, Gisli; Wells, Athol U; Wort, Stephen J; Price, Laura C.
Afiliação
  • Dawes TJW; National Heart and Lung Institute, Imperial College London, London, UK.
  • McCabe C; National Heart and Lung Institute, Imperial College London, London, UK.
  • Dimopoulos K; National Pulmonary Hypertension Service, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Stewart I; National Heart and Lung Institute, Imperial College London, London, UK.
  • Bax S; National Pulmonary Hypertension Service, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Harries C; Adult Congenital Heart Disease Service, Royal Brompton Hospital, London, UK.
  • Samaranayake CB; National Heart and Lung Institute, Imperial College London, London, UK.
  • Kempny A; National Pulmonary Hypertension Service, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Molyneaux PL; National Pulmonary Hypertension Service, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Seitler S; National Heart and Lung Institute, Imperial College London, London, UK.
  • Semple T; National Heart and Lung Institute, Imperial College London, London, UK.
  • Li W; National Pulmonary Hypertension Service, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • George PM; Adult Congenital Heart Disease Service, Royal Brompton Hospital, London, UK.
  • Kouranos V; National Heart and Lung Institute, Imperial College London, London, UK.
  • Chua F; Department of Interstitial Lung Disease, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Renzoni EA; National Pulmonary Hypertension Service, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Kokosi M; National Heart and Lung Institute, Imperial College London, London, UK.
  • Jenkins G; Department of Radiology, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Wells AU; National Heart and Lung Institute, Imperial College London, London, UK.
  • Wort SJ; Adult Congenital Heart Disease Service, Royal Brompton Hospital, London, UK.
  • Price LC; Department of Echocardiography, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Respirology ; 28(3): 262-272, 2023 03.
Article em En | MEDLINE | ID: mdl-36172951
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Pulmonares Intersticiais / Hipertensão Pulmonar Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Pulmonares Intersticiais / Hipertensão Pulmonar Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article